- Home
- ALEX vs NVCR Comparison
ALEX vs NVCR Comparison
Compare ALEX & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEX
- NVCR
- Stock Information
- Founded
- ALEX 1870
- NVCR 2000
- Country
- ALEX United States
- NVCR Switzerland
- Employees
- ALEX N/A
- NVCR N/A
- Industry
- ALEX Real Estate Investment Trusts
- NVCR Medical/Dental Instruments
- Sector
- ALEX Real Estate
- NVCR Health Care
- Exchange
- ALEX Nasdaq
- NVCR Nasdaq
- Market Cap
- ALEX 1.3B
- NVCR 1.4B
- IPO Year
- ALEX N/A
- NVCR 2015
- Fundamental
- Price
- ALEX $19.05
- NVCR $12.43
- Analyst Decision
- ALEX Buy
- NVCR Buy
- Analyst Count
- ALEX 2
- NVCR 7
- Target Price
- ALEX $24.00
- NVCR $28.79
- AVG Volume (30 Days)
- ALEX 350.3K
- NVCR 1.9M
- Earning Date
- ALEX 07-24-2025
- NVCR 07-24-2025
- Dividend Yield
- ALEX 4.73%
- NVCR N/A
- EPS Growth
- ALEX 94.65
- NVCR N/A
- EPS
- ALEX 1.07
- NVCR N/A
- Revenue
- ALEX $238,308,000.00
- NVCR $630,160,000.00
- Revenue This Year
- ALEX N/A
- NVCR $6.68
- Revenue Next Year
- ALEX $1.76
- NVCR $7.01
- P/E Ratio
- ALEX $17.74
- NVCR N/A
- Revenue Growth
- ALEX 8.21
- NVCR 14.58
- 52 Week Low
- ALEX $15.70
- NVCR $10.87
- 52 Week High
- ALEX $20.11
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- ALEX 65.36
- NVCR 46.30
- Support Level
- ALEX $18.48
- NVCR $11.55
- Resistance Level
- ALEX $18.82
- NVCR $12.26
- Average True Range (ATR)
- ALEX 0.25
- NVCR 0.46
- MACD
- ALEX 0.05
- NVCR 0.30
- Stochastic Oscillator
- ALEX 93.46
- NVCR 97.50
About ALEX Alexander & Baldwin Inc. REIT Holding Company
Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.